Patents by Inventor Hajime Fujinaga

Hajime Fujinaga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240099394
    Abstract: A controller for an inhalation apparatus operates by electric power supplied from a chargeable power supply. The controller includes a holding portion configured to hold an atomizer including a heater configured to heat an aerosol source, a nonvolatile display configured to display an indicator concerning a remaining amount of the power supply, and a processor configured to change the indicator in a case where the remaining amount becomes smaller than a first threshold in discharging of the power supply, and to change the indicator in a case where the remaining amount becomes larger than a second threshold different from the first threshold in charging of the power supply.
    Type: Application
    Filed: December 6, 2023
    Publication date: March 28, 2024
    Applicant: Japan Tobacco Inc.
    Inventors: Ikuo FUJINAGA, Hajime FUJITA
  • Publication number: 20240100275
    Abstract: A controller for an inhalation apparatus, which operates by electric power supplied from a power supply, includes a holding portion configured to hold an atomizer including a heater configured to generate flavored aerosol from a generation source of an aerosol source, a nonvolatile display; and a processor configured to control update of display of the nonvolatile display, wherein the processor determines whether to perform the update in response to occurrence of a factor for changing a remaining amount of the generation source.
    Type: Application
    Filed: December 6, 2023
    Publication date: March 28, 2024
    Applicant: Japan Tobacco Inc.
    Inventors: Ikuo FUJINAGA, Kentaro YAMADA, Hajime FUJITA
  • Patent number: 10370632
    Abstract: In order to culture the pluripotent stem cell which can be variously differentiated, while preventing the cross contamination between the different cells and securing the safety of the products; extending a main transport path 31 outwardly from a stem cell conditioning area 20, the stem cell conditioning area 20 including a treatment room 21 for inducing pluripotent stem cell from a somatic cell or an egg cell, or a treatment room 21 for receiving and conditioning pluripotent stem cell induced in other facilities; branching at least one branched transport path 32 from the main transport path 31; and arranging along each branched transport path 32, a cell culture area 40 including culture rooms 41 to 44 for culturing the stem cell and an analysis room 45 for analyzing the cultured cell, respectively.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: August 6, 2019
    Assignee: Kajima Corporation
    Inventors: Toshimitsu Fuji, Shigenori Ozaki, Yoshio Kinoshita, Hajime Fujinaga, Ryoji Shiina, Atsushi Nishida
  • Publication number: 20160272929
    Abstract: In order to culture the pluripotent stem cell which can be variously differentiated, while preventing the cross contamination between the different cells and securing the safety of the products; extending a main transport path 31 outwardly from a stem cell conditioning area 20, the stem cell conditioning area 20 including a treatment room 21 for inducing pluripotent stem cell from a somatic cell or an egg cell, or a treatment room 21 for receiving and conditioning pluripotent stem cell induced in other facilities; branching at least one branched transport path 32 from the main transport path 31; and arranging along each branched transport path 32, a cell culture area 40 including culture rooms 41 to 44 for culturing the stem cell and an analysis room 45 for analyzing the cultured cell, respectively.
    Type: Application
    Filed: July 11, 2014
    Publication date: September 22, 2016
    Inventors: Toshimitsu Fuji, Shigenori Ozaki, Yoshio Kinoshita, Hajime Fujinaga, Ryoji Shiina, Atsushi Nishida